Viadur Related Clinical Trials
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy [Active, not recruiting]
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer [Completed]
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF [Completed]
Study of Lupron Depot In The Treatment of Central Precocious Puberty [Active, not recruiting]
Melanoma Vaccine With Peptides and Leuprolide [Recruiting]
Safety Extension Study Of Lupron Depot In The Treatment Of Central Precocious Puberty [Not yet recruiting]
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty [Recruiting]
A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD [Active, not recruiting]
Lupron Sex Offender Therapy [Active, not recruiting]
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation [Recruiting]
Leuprolide or Goserelin Plus Thalidomide Compared With Leuprolide or Goserelin Alone in Treating Patients With Nonmetastatic Prostate Cancer [Active, not recruiting]
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer [Completed]
A Study of Leuprolide 45 mg Formulation to Treat Prostate Cancer [Recruiting]
Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer [Active, not recruiting]
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) [Recruiting]
ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation [Completed]
Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism [Completed]
Understanding Experimentally Induced Hot Flushes [Active, not recruiting]
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study: A Phase II Study of Chemo – Hormonal Therapy and Radiation in High Risk Prostate Cancer [Not yet recruiting]
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients [Recruiting]
Leuprolide in Treating Adults With Hypogonadotropism [Recruiting]
Leuprolide in Determining the Cause of Gonadotropin Deficiency [Recruiting]
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer [Completed]
Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study [Completed]
Regulation of Cortisol Metabolism and Fat Patterning [Recruiting]
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy [Active, not recruiting]
Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate [Active, not recruiting]
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer [Active, not recruiting]
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients [Recruiting]
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA [Recruiting]
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer [Recruiting]
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer [Recruiting]
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer [Recruiting]
Medical Treatment of Endometriosis-Associated Pelvic Pain [Recruiting]
Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease [Completed]
A Treatment Study for Premenstrual Syndrome (PMS) [Recruiting]
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome [Completed]
Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy [Active, not recruiting]
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea [Recruiting]
Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea [Recruiting]
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma [Completed]
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer [Completed]
Combined Hormone Replacement in Menstrually-Related Mood Disorders [Recruiting]
A Comparison of the Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Women Who Are or Who Are Predicted to be Low Responders [Recruiting]
Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer [Active, not recruiting]
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) [Completed]
To Lengthen the Duration of the Off-Treatment of Intermittent Androgen Suppression [Active, not recruiting]
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone [Completed]
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle [Active, not recruiting]
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer [Active, not recruiting]
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer [Completed]
Pazopanib After Leuprolide or Goserelin in Treating Patients With Relapsed Prostate Cancer [Recruiting]
Clinical Trial for Prostate Cancer [Completed]
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer [Recruiting]
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
Randomized Study of Hormonal Regulation of Infantile Hemangioma
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Prevention of Obesity in Women Via Estradiol Regulation [Recruiting]
Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer [Completed]
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer [Completed]
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Active, not recruiting]
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer [Terminated]
Study, Investigating the Efficacy and Safety of Degarelix One Month Dosing Regimens [Active, not recruiting]
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases [Active, not recruiting]
Adjuvant Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0M0 Prostate Cancer [Recruiting]
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer [Recruiting]
Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer [Recruiting]
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer [Not yet recruiting]
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer [Recruiting]
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Androgen Deprivation Therapy for Metastatic Prostate Cancer [Recruiting]
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer [Recruiting]
Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer [Recruiting]
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Recruiting]
Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer [Recruiting]
Comparison of Two Pharmacological Treatments of Pedophilia [Recruiting]
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy [Recruiting]
Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism [Recruiting]
Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy [Recruiting]
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer [Active, not recruiting]
Purification of Testis-Stimulating Factor in Precocious Puberty [Completed]
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer [No longer recruiting]
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer [No longer recruiting]
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer [Completed]
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer [Completed]
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer [Active, not recruiting]
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [Withdrawn]
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer [Active, not recruiting]
The Use of GnRH Agonist Trigger in the Prevention of OHSS [Completed]
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children [Recruiting]
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-Menopausal Women With Symptomatic Uterine Fibroids [Recruiting]
Hormonal Causes of Menstrual-Related Mood Disorders [Recruiting]
Insulin Resistance and Testosterone in Women [Recruiting]
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Recruiting]
Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy. [Recruiting]
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy [Recruiting]
|
